Pure Global AI
NCT05992701Recruiting

Effectiveness and Safety of Directional Deep Brain Stimulation for Parkinson's Disease

Beijing Pins Medical Co., LtdClinicalTrials.govdeviceDevice trial
Verified
Study focus
Disease/Condition
Parkinson's Disease
Drug/Device/Intervention
Directional deep brain stimualtion
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Beijing Pins Medical Co., Ltd
Location
Beijing,Beijing,Chengdu,Kunming,Nanjing,Shanghai,Shenzhen,Tianjin,Wuhan, China
Timeline & enrollment
Phase
N/A
Start date
Jul 28, 2021
End date
Jun 30, 2024
Enrollment
28 participants
Primary outcome

Therapeutic Window

Summary

The purpose of this study is to demonstrate the safety and effectiveness of the PINS Deep
 Brain Stimulation (DBS) system, including the G107R/G107 IPG, L305/L306 directional leads,
 E204 extensions and related system components.

ICD-10 classifications
Parkinson diseaseParkinsonism in diseases classified elsewhereDementia in Parkinson diseaseSecondary parkinsonismPostencephalitic parkinsonism
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05992701
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT05992701 through Pure Global AI's free database. This phase not specified trial is sponsored by Beijing Pins Medical Co., Ltd and is currently Recruiting. The study focuses on Parkinson's Disease. Target enrollment is 28 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.